CME SLIDES FORUM

Archive

viklicky

Molecular predictors of outcome

 

 

 

 

Reinke

Prevention and treatment of BKV nephropathy

 

 

 

 

Prof Ondrej Viklicky
Department of Nephrology
Transplant Center
Institute for Clinical and Experimental Medicine
Prague, Czech Republic
Prof Petra Reinke
Department of Nephrology
University Hospital Charité
Berlin, Germany
   
Verbeke

Post transplantation cardiovascular disease

soulillou

Immune correlate of operational tolerance of mismatched transplant in human

Dr Francis Verbeke
Department of Internal Medicine
Nephrology Section
University Hospital Ghent
Ghent, Belgium
Prof Jean Paul Soulillou
Institut de Transplantation et de Recherche en Transplantation
ITERT
CHU Nantes
Nantes, France
   
volk

Drug minimisation from bench to bedside – some lessons from the riset program

 
Prof Hans-Dieter Volk
Institute of Medical Immunology
University Hospital Charité
Berlin, Germany
 

 

Mallamaci

Medical aspects of depression in dialysis

 

 

 

Levin

Multidisciplinary care models

 

 

 

Dr F. Mallamaci
Nephrology, Dialysis, Transplantation and Hypertension Unit,
OO.RR and CNR Istituto di Biomedicina,
Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione
Reggio Calabria, Italy
Prof. Adeera Levin
Clinical Professor of Medicine
University of British Columbia
Vancouver, Canada
   
Kouidi

Exercise rehabilitation outcomes in CKD patients

   
Prof. Evangelia Kouidi
Sports Medicine Laboratory
Aristotele University of Thessaloniki
Thessaloniki, Greece
 

 

Breithardt

Atrial fibrillation and oral anticoagulants

 

 

Amann

Sympathatic overactivity in CKD: mechanisms and clinical implications

 

 

Prof Günter Breithardt
Department of Cardiology and Angiology
Hospital of the University of Münster
Münster, Germany
Prof Kerstin Amann
Abt. für Nephropathologie
Pathologisches Institut
Universitätsklinikum Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Germany
   
Goldsmith

Sudden death in chronic kidney disease - a neglected priority for intervention

Zoccali

Biomarkers of sympathetic activity and cardiovascular risk in CKD

Dr David J A Goldsmith
Renal Unit
Guy's Hospital
London, United Kingdom
Prof Carmine Zoccali
Unità di Nefrologia, Dialisi, Trapianto e Ipertensione
OO.RR and CNR Istituto di Biomedicina
Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione
Reggio Calabria, Italy

 

Molitoris

Thinking through the biomarker dilemma

 

 

 

Soni

NGAL – a biomarker for AKI and other systemic conditions

 

 

 

Prof. Bruce A. Molitoris
Department of Medicine
Indiana University and the Roudebush VA Medical Center
Indianapolis, Indiana, USA
Dr. Sachin Soni
Department of Nephrology
Manik Hospital and Research Centre
Aurangabad, India
   
Liangos KIM-1  
Dr. Orfeas Liangos
Klinikum Coburg
III. Med. Klinik
Coburg, Germany
 

 

Daroux

Age’s, rage and diabetic nephropathy

 

 

Persson

How to slow down the progression of diabetic nephropathy

 

 

Dr. Maité Daroux
Service de Néphrologie
Hôpital Duchenne
Boulogne-sur-Mer, France
Dr. Frederik Persson
Steno Diabetes Center
Gentofte, Denmark

 

Brunet

Does uraemia cause vascular dysfunction?

 

 

 

 

Boutouyrie

Arterial stiffness in adult patients with chronic kidney diseases

 

 

 

 

Prof. Philippe Brunet
Service de Néphrologie
Hôpital de la Conception
Marseille, France
Prof. Pierre Boutouyrie
Department of Pharmacology
Hôpital Européen George Pompidou
Paris, France
   
covic

Heart involvement in CKD: from large arteries stiffness to microvascular disease

 

   
Prof. Adrian Covic
Dialysis and Renal Transplantation Unit
“C. I. Parhon” University Hospital
Iasi, Romania
 

 

Ronco

Renal complications of myeloma and related disorders: an update

 

 

 

Fermand

Treatment and monitoring of al-amyloidosis: the evolving story

 

 

 

Prof. Pierre Ronco
Service de Nephrologie
Hôpital Tenon
Paris, France
Prof. Jean Paul Fermand
Service d'Immuno-Hematologie
Hôpital Saint Louis
Paris, France
   
Roccatello

Renal involvement in essential mixed cryoglobulinemia

Hutchison

Treatment of myeloma cast nephropathy with high cut-off dialysis

Prof. Dario Roccatello
CMID
Ospedale San Giovanni Bosco
Turin, italy
Dr. Colin Hutchison
Renal Institute of Birmingham
University Hospital Birmingham and University of Birmingham
Birmingham, United Kingdom

 

Davenport

Tayloring dialysis for the septic patient

 

 

 

Hoste

Epidemiology of AKI in the ICU

 

 

 

Prof. Andrew Davenport
UCL Centre for Nephrology
Royal Free Hospital
London, United Kingdom
Dr. Eric Hoste
ICU
Gent University Hospital
Gent, Belgium

 

Abramowicz

PRotocol biopsy - Con

 

 

 

 

Schwarz

Protocol biopsy - Pro

 

 

 

Dr. Daniel Abramowicz
Renal Transplantation Clinic
Hopital Erasme
Brussels, Belgium
Prof. Anke Schwarz
Medizinische Hochschule Hannover
Abteilung Nephrologie
Hannover, Germany
   
Lerut

Update on Banff 07 criteria

 

 

 

Meyrier

Direct effect of calcineurin inhibitors and corticosteroids on podocytes

 

 

 

Prof. Evelyne Lerut
Dept. of Pathology
University Hospital Leuven
Leuven, Belgium
Prof. Alain Meyrier
Service de Néphrologie
Hopital Georges Pompidou
Paris, France

 

Mischak

Peptides and vascular disease

 

 

 

 

Fliser

High density lipoprotein and vascular function

 

 

 

Prof. Harald Mischak
Mosaiques Diagnostics & Therapeutics
Hannover, Germany
Prof. Danilo Fliser
Renal and Hypertensive Disease
University Medical Centre
Homburg/Saar, Germany
   
Argiles

Removal of peptides by dialysis

 

 

Vanholder

Clinical impact of peptides in uremia

 

 

Prof. Angel Argiles
Nephrologie Dialyse
St. Guilhem, Sète
Montpellier, France
Prof R. Vanholder
Professor of Medicine at the University of Ghent, Belgium,
Associate Head of the Nephrology Division of the Ghent University Hospital
Ghent, Belgium

 

   
Johnson

Organ allocation – principles and practice 

 

 

 

 

Fronek

Living Donation

 

 

Dr. Rachel Johnson
Organ Donation and Transplant
NHS Blood and Transplant
Briston, United Kingdom
Dr. Jiri Fronek
Renal Transplant Unit
St. George's Hospital NHS Trust
London, United Kingdom
   
Heemann

What is standard immunosuppression in 2011?

 

Campistol

Late complications and their management

 

Prof. Uwe Heemann
II. Medizinische Klinik und Poliklinik
der Technischen Universitaet Muenchen
Klinikum rechts der Isar
Abteilung fuer Nephrologie
Munich, Germany
Prof. J.M. Campistol
Nephrology and Renal Transplant Department
Hospital Clinic
Universtity of Barcelona
Barcelona, Spain

 

Foidart

News in the pathogenesis and treatment of preeclampsia

 

 

 

Piccoli

Pregnancy in chronic kidney disease: a diagnostic and therapeutic challenge from the early stages of CKD

 

 

Prof. Jean-Michel Foidart
Department of Obstetrics and Gynecology
University of Liège
Liège, Belgium

Dr. Giorgina B. Piccoli
SS Nephrology
Department of Clinical and Biological Sciences
San Luigi University Hospital
Turin, Italy
   
Imbasciati

Pregnancy and lupus nephritis. Predictors of foetal and maternal outcomes

Smaill

Asymptomatic bacteriuria and urinary tract infection in pregnancy

Dr. Enrico Imbasciati
Chair of Nephrology
Milano Bicocca University
Milan, Italy
Prof. Fiona Smaill
Department of Pathology and Molecular Medicine
McMaster University
Hamilton, ON, Canada

 

   
Van Den Berghe

Glycemic control to prevent AKI

 

 

 

 

Reddan

Choice of fluids and prevention of AKI

 

 

 

 

Prof. Greet Van Den Berghe
Department of Intensive Care Medicine
University Hospital Gasthuisberg
Leuven, Belgium
Dr. Donald Reddan
University College Galway
Merlin Park Hospital
Galway, Ireland
   

 

Ketteler

The link between ckd/mbd and blood vessels

 

 

 

Wagner

Physiology of renal p-handling and therapeutic consequences

 

 

 

Prof M. Ketteler
Nephrologische Klinik
Klinikum Coburg
Coburg, Germany
Prof Carsten Wagner
Institute of Physiology
University of Zürich
Zürich, Switzerland
   
Cannata

Osteoporosis, adynamic bone disease and CKD

 

 

 

 

 

Prof J. Cannata-Andia
Servicio de Metabolismo Oseo y Mineral
Instituto “Reina Sofía” de Investigación.
REDinREN – ISCIII.
Hospital Universitario Central de Asturias.
Universidad de Oviedo
Oviedo, Spain
 

 

coppo

Is a legacy effect possible for IGA Nephropathy?

 

 

 

Schena

Genomics in IGA Nephropthy

 

 

 

 

Prof R. Coppo
Director of the Nephrology, Dialysis and Transplantation Department
Regina Margherita Hospital
Turin, Italy
Prof. Francesco Paolo Schena
Head of the Nephrology,
Dyalisis and Transplant Unit of Bari University
Bari, Italy
   
Floege

Recurrence of IGA Nephropathy after kidney transplantation

 

 

Roberts

Histologic markers indicating the need for therapeutic intervention in IGA Nephropathy

Prof Jürgen Floege
Division of Nephrology
RWTH University of Aachen
Aachen, Germany
Dr Ian Roberts
Department of Cellular Pathology
John Radcliffe Hospital
Oxford, United Kingdom

 

Barany

Adipokine signaling and the kidney

 

 

 

 

Lafontan

Metabolic role of natriuretic peptide – is it important for renal failure? 

 

 

 

Dr. Peter Barany
Division of Renal Medicine
Department of Clinical Science, Intervention, and Technology
Karolonska Institutet
Karolinska University Hospital
Stockholm, Sweden
Dr. Max Lafontan
UMR 1048
Institut des Maladies Métaboliques
et Cardiovasculaires
Toulouse, France
   
Gansevoort

Vasopressin as a risk factor for CKD 

 

 

 

 

 
Prof. Ron T. Gansevoort
Department of Nephrology
University Medical Center Groningen
University of Groningen
Groningen, The Netherlands
 

 

Titze

Salt in space

 

 

 

Beelen

Angiogenesis in peritoneal dialysis

 

 

Dr. Jens Titze
Medizinischeklink IV
Universitaet Erlangen-Nürnberg
Erlangen, Germany
Prof. Robert H.J. Beelen
Department of Molecular Cell Biology and Immunology
VU University Medical Center
Amsterdam, The Netherlands
   
Hugo

Therapeutic inhibition of angiogenesis and the kidney

 

 

 

 
Prof. Christian Hugo
Universitaetsklinikum Carl Gustav Carus
Medizinische Klinikum III
Dresden, Germany
 

 

Weimar

Living donor exchange programme

 

 

 

Abramowicz

Genetics of renal allograft rejection

 

 

Prof. Willem Weimar
Department of Kidney Transplantation
Erasmus Medical Center
Rotterdam, The Netherlands
Dr. Marc Abramowicz
Genetics Department
Hôpital Erasme - ULB
Brussels, Belgium
   
Arns

Extended criteria donors: where is the limit?

 

 

 
Dr. Wolfgang Arns
Cologne General Hospital
Merheim Medical Center
Cologne, Germany
 

 

Rottey

Side effects of medical treatment of cancer

 

 

 

 

Desmeules

Phosphate and biphosphonate

 

 

 

Dr. Sylvie Rottey
Department of Oncology
Ghent University Hospital
Ghent, Belgium
Dr. Simon Desmeules
Department of Medicine
Centre Hospitalier Universitaire de Québec-Hôtel-Dieu de Québec
Québec City, Canada
   
marenzi

Contrast

 

 
Dr. Giancarlo Marenzi
Department of Cardiovascular Sciences
University of Milan
Milan, Italy
 

 

Kielstein

Extended (daily) dialysis

 

 

 

Sever

Dialysis choice in disaster circumstances

 

 

Prof. Jan T. Kielstein
Dept. of Nephrology and Hypertension
Medical School Hannover
Hannover, Germany
Prof. Mehmet Sukru Sever
Dept. of Internal Nephrology
Istanbul School of Medicine
Istanbul, Turkey
   
Van Biesen

Intermittent or continuous: anything new?

 

 
Prof. Wim Van Biesen
Renal Division
University Hospital Ghent
Ghent, Belgium
 

 

Camussi

Microvesicle - mediated transfer of genetic information

 

 

Sallustio

TLR2 and activation of human resident renal stem/progenitor cells

 

 

 

 

Prof. Giovanni Camussi
Department of Internal Medicine,
Centre for Molecular Biotechnology
and Centre for Research in Experimental Medicine (CeRMS)
Torino, Italy
Dr. Fabio Sallustio
Nephrology, Dialysis and Transplantation Unit
Department of Emergency and Organ Transplantation
University of Bari
Bari, Italy
   
Moeller

Parietal cells: an emerging cell type and its role in FSSG

 
Dr. Marcus J. Moeller
Department of Nephrology and Clinical Immunology
University Hospital of RWTH
Aachen University
Aachen, Germany
 

 

Böger

Renal function, albuminuria and CKD: insights from genome-wide association studies

 

nordfors

Epigenetics and kidney disease

 

 

 

Dr. Carsten Böger
Dept. Internal Medicine 2
University Medical Center
Regensburg, Germany
Dr. Louise Nordfors
Department of Molecular Medicine and Surgery
Neurogenetics Unit
Karolinska University Hospital
Stockholm, Sweden

 

Schetz

AKI

 

 

Feehally

Glomerulonephritis

 

 

Prof. Miet Schetz
Department of Intensive Care Medicine
University of Leuven
Leuven, Belgium

Prof J. Feehally
Dept of Nephrology
Leicester General Hospital
Leicester, United Kingdom
   
Tesar Progression of kidney failure Dusilova Sulkova Haemodialysis
Prof. Vladimir Tesar
Department of Nephrology
First Faculty of Medicine
Charles University
Prague, Czech Republic
Prof. Silvie Dusilova Sulkova
Department of Nephrology
Institute for Clinical and Experimental Medicine
Prague, Chzech Republic
   
Heimburger Peritoneal Dialysis  
Dr. Olof Heimbürger
Div. Renal Medicine, K56
Karolinska University Hospital
Stockholm, Sweden
 

 

   
Summers

Encapsulating peritoneal sclerosis

 

 

Brandenburg

Calciphylaxis

 

 

Dr Angela M. Summers
Renal Research Labs
Manchester Royal Infirmary
Manchester, United Kingdom
Dr V.M. Brandenburg
Department of Nephrology & Clinical Immunology
University Hospital Aachen
Aachen, Germany
   

 

Dekker

Ideal time for starting renal replacement therapy

 

Viglino

Which role for incremental peritoneal dialysis

 

Dr Friedo Dekker
Clinical Epidemiology
Leiden University Medical Center
Leiden, The Netherlands
Dr Giusto Viglino
Nephrology and Dialysis
Hospital San Lazzaro
Alba, Italy

   
Povlsen

Unplanned start on assisted peritoneal dialysis

 
Dr Johan V. Povlsen
Department of Renal Medicine C
Aarhus University Hospital
Skejby
Aarhus, Denmark

 

 

   
Rutkowski

RAAS blockade in native and grafted kidneys

 

 

 

 

Rostaing

Is there a role for new anti-b cells and anti-complement agents in kidney transplant patients

Prof  Przemyslaw Rutkowski
Chair and Department of Nephrology
Transplantation and Internal Diseases
Medical University Gdansk
Gdansk, Poland

Prof  Lionel Rostaing
Organ Transplant Unit
Nephrology and Dialysis Unit
CHU Toulouse-Rangueil
Toulouse, France

 

De Francisco

Hemoglobin variability in non-dialysis CKD patients

 

 

 

 

locatelli

Anemia management in patients with CKD: European Best Practice Recommendations

Prof  A.L.M. De Francisco
Universidad de Cantabria
Chief Clinic of the Nephrology Department
Valdecilla Universitary Hospital
Santander, Spain

Prof. F. Locatelli
Dipartimento Nefro-Urologico
Ospedale "A. Manzoni"
Lecco, Italy
   
Reddan

Modifying iron balance in CKD patients, is BMP signalling a reasonable target?

 
Dr. Donald Reddan
University College Galway
Merlin Park Hospital
Galway, Ireland

 

 

Ballarin

Current therapies in membranous nephropathy

 

 

 

 

   
Dr José Ballarin
Fundació Puigvert
Barcelona, Spain
 

 

Daha

Organization and activities of the Immunonephrology Working Group

 

 

 

Floege

Proposals of new collaborative studies on rare diseases and recurrent glomerular diseases after transplantation

 

 

Prof M.R. Daha
Dept of Nephrology
Leiden University Medical Center
Leiden, The Netherlands

Prof Jürgen Floege
Division of Nephrology
RWTH University of Aachen
Aachen, Germany

 

Chmielewski

Nutritional initiatives to decrease cardiovascular risk in CKD

 

 

uppsala

Limitations of statin treatment in the prevention of cardiovascular events in dialysis patients

 

Dr  Michal Chmielewski
Department of Nephrology, Transplantology and Internal Medicine
Medical University
Gdansk, Poland

Prof  Bengt Fellström
Department of Nephrology
University Hospital,
Uppsala, Sweden

       
Massy

Atherosclerosis and vascular calcification and CKD - insights from animal models

 

 

   
Prof  Ziad Massy
Nephrology and Clinical Pharmacology Departments
University Hospital of Amiens
Amiens, France

 

 

Ronco

Is cardiorenal syndrome a new entity? Pro

 

 

 

 

Hoerl

Is cardiorenal syndrome a new entity? Con

 

 

 

 

Dr. Claudio Ronco
Divisione di Nefrologia
Ospedale San Bortolo
Vicenza, Italy

Prof. Walter H. Hörl
Division of Nephrology and Dialysis
Department of Medicine III
Medical University of Vienna
Vienna, Austria

       
Navis

Impact of various manifestations of renal dysfunction on heart failure

 

 

 

 

   
Prof. Cerjan Navis
Chair of Experimental Nephrology and Renal Pharmacology
Department of Medicine
University Medical Center
Groningen, The Netherlands
 

 

Lafage-Proust

The culprit of osteoporosis in CKD

 

 

 

evenpoel

Calcium metabolism changes after transplantation

 

 

 

Prof Marie-Helene Lafage-Proust
Université de Lyon
Institut National de la Santé et de la Recherche Medical
(INSERM) 890, CHU
Saint-Etienne, France

Dr. Pieter Evenepoel
Div. Nephrology, Dialysis and Transplantation
University Hospital Gasthuisberg
Leuven, Belgium

       
Bover

Adynamic bone disease: from bone to vessels

 

 

 

   
Dr. Jordi Bover
Fundació Puigvert
Barcelona, Spain
 

 

schena

Potential repairing process of renal progenitor cells in tubular damage

 

 

 

 

Erasmus

Aldosterone-receptor antagonism in hypertension: where do we stand

 

 

 

Prof. Francesco Paolo Schena
Head of the Nephrology,
Dyalisis and Transplant Unit of Bari University
Bari, Italy

Dr. Anton H. van den Meiracker
Division of Pharmacology
Vascular and Metabolic Diseases
Department of Internal Medicine
Erasmus Medical Center
Rotterdam, The Netherlands

       
Verbeke

Arterial stiffness in renal transplant recipients

 

 

   
Dr. Francis Verbeke
Renal Unit
University Hospital Gent
Gent, Belgium
 

 

mamodeslide

Polyomavirus infection in renal transplantation

 

 

 

Uwe Heemann, Munich, Germany

Immunosuppression

 

 

Dr. Cristina Costa
Virology Unit
Department of Public Health and Microbiology
University of Turin
Turin, Italy

Prof. Uwe Heemann
II. Medizinische Klinik und Poliklinik
der Technischen Universitaet Muenchen
Klinikum rechts der Isar
Abteilung fuer Nephrologie
Munich, Germany

       
Mamode

What should we be doing about renal preservation?

 

 

Campistol

Sustained improvement of graft survival: is it feasible?

Dr. Nizam Mamode
Guys and Great Ormond Street Hospitals
MRC Centre for Transplantation and NIHR Biomedical
Research Centre
London, United Kingdom
Prof. J.M. Campistol
Nephrology and Renal Transplant Department
Hospital Clinic
Universtity of Barcelona
Barcelona, Spain
   
Opelz

Current impact of HLA compatibility and immunosuppression on graft survival

 
Prof. G. Opelz
Institute of Immunology
University of Heidelberg
Heidelberg, Germany
 

 

Anding-rost

The impact of physical fitness on morbidity and quality of life in patients with CKD

 

 

Mercer

The effects of exercise training on muscle with special reference to patients with CKD

 

 

Dr. Kirsten Anding-Rost
KfH-Nierenzentrum
Bischofswerda, Germany

Prof. Tom Mercer
School of Health Sciences
Faculty of Health and Social Science
Queen Margaret University College
Edinburgh, United Kingdom

       
Krause

Physical fitness - an integral part of comprehensive care of CKD patients

 

   
Prof. Rolfdieter Krause
KfH - Dialysezentrum Moabit
Berlin, Germany
   

 

Hoerl

Arrhythmias in dialysis patients

 

 

Oberbauer

Biocompatibility and genomics in dialysis

 

 

 

Prof. Walter H. Hörl
Division of Nephrology and Dialysis
Department of Medicine III
Medical University of Vienna
Vienna, Austria

Dr. Rainer Oberbauer
Department of Nephrology
KH Elisabethinen
Linz and Medical University of Vienna
and Austrian Dialysis and Transplant Registry
Vienna, Austria

       
McIntyre

Impact of a haemodialysis session for myocardial perfusion

   
Dr. Christopher W. McIntyre
Department of Renal Medicine
Royal Derby Hospital
Derby, United Kingdom
   

 

Espinosa

C4D deposition in IGA Nephropathy

 

Roberts

Renal biopsy in IGA Nephropathy: the Oxford classification and beyond

 

 

Dr Mario Espinosa
Nephrology Department
University Hospital Reina Sofia
Cordoba, Spain

Dr Ian Roberts
Department of Cellular Pathology
John Radcliffe Hospital
Oxford, United Kingdom

       

 

Rippe

Pathophysiology of the peritoneal interstitium and mesothelial cells in ultrafiltration failure (UFF)

 

Teta

Dynamic interactions between peritoneum and abdominal adipocytes: the effect of peritoneal dialysis solutions

 

 

 

Prof Bengt Rippe
Nephrology Department
University Hospital Lund
Lund, Sweden

Dr Daniel Teta
Division de Nephrologie
CHUV Lausanne
Lausanne, Switzerland

       
Cancarini

Current outcomes in peritoneal dialysis

 

 

Chanliau

Financial aspects in peritoneal dialysis

 

Prof Giovanni Cancarini
U.O. Nefrologia
A.O. Spedali Civili di Brescia
Brescia, Italy
Dr Jacques Chanliau
Association lorraine de traitement de l'insuffisance rénale (ALTIR)
Vandœuvre, France
   
Daviea

Multicenter experience with low-sodium peritoneal dialysis solutions

 
Prof Simon J Davies
Department of Nephrology
North Staffs Royal Infirmary
Stoke-on-Trent, United Kingdom
 

 

friedlander

Klotho, FG23 and Vitamin d: a bone-kidney story and much more

 

 

 

cannata

Beyond CA/P/PTH: clinical evidence of a link between the adipose tissue and bone disease in ESRD

 

 

Prof Gérard Friedlander
Département de Physiologie et Radio-Isotopes
Hôpital Européen Georges Pompidou
Paris, France

Prof Andrzej. Wiecek
Department of Nephrology, Endocrinology and Metabolic Diseases
Silesian University School of Medicine
Katowice, Poland

       
Schurgers

Vascular calcifications as a risk factor for cardiovascular mortality

 

cannata

Vascular calcification: can we control progression and regression?

Dr Leon Schurgers
Department of Biochemistry
University Maastricht
Maastricht, The Netherlands
Prof J. Cannata-Andia
Servicio de Metabolismo Oseo y Mineral
Instituto “Reina Sofía” de Investigación.
REDinREN – ISCIII.
Hospital Universitario Central de Asturias.
Universidad de Oviedo
Oviedo, Spain

 

   
chu logo

Optimization of immunosuppressants dosing in renal transplantation

 

 

 

 

Kuypers

Genome wide analysis and transplantation: what is it and what could it bring us?

 

 

 

Prof Yannick Le Meur
Service de Néphrologie
CHU la Cavale Blanche
Brest, France

Prof  Dirk R.J. Kuypers
Department of Nephrology and Renal Transplantation
University of Leuven
Leuven, Belgium

       
manuel

Population pharmacokinetics in renal transplantation

 

   
Prof  Oriol Manuel
Transplantation Center and Service of Infectious Diseases
University Hospital of Lausanne
Lausanne, Switzerland

   

 

Massy

New insights from clinical studies

 

 

 

Vanholder

Metabolism

 

 

 

Prof  Z. Massy
Nephrology and Clinical Pharmacology Departments,
University Hospital of Amiens,
Amiens, France

Prof R. Vanholder
Professor of Medicine at the University of Ghent, Belgium,
Associate Head of the Nephrology Division of the Ghent University Hospital
Ghent, Belgium

       
Zoccali

Biomarkers: when is it justified to incorporate a new biomarker into clinical practice?

   
Prof C. Zoccali
Unità di Nefrologia, Dialisi, Trapianto e Ipertensione
OO.RR and CNR Istituto di Biomedicina
Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione
Reggio Calabria, Italy
   

 

Meyrier

Update on the treatment of idiopathic FSGS

 

 

 

 

Savin

Cardiotrophin-like cytokine-1, potential FSGS permeability factor

 

 

 

 

Prof. Alain Meyrier
Department of Nephrology
University Paris-Descartes
Hôpital Georges Pompidou and Broussais
Paris, France

Prof. Virginia Savin
Kidney Institute
University of Kansas Medical Center
Kansas City, KS, USA

 

de broe

Inflammatory mechanisms in AKI

 

 

 

Ortiz

TWEAK/FN14 in acute kidney injury

 

 

 

Prof. Marc De Broe
Department of Nephrology
University of Antwerp
Antwerpen, Belgium

Dr. Alberto Ortiz
Dpto de Nefrología Experimental y Patología Vascular
IIS-Fundación Jiménez Díaz
Madrid, Spain

       

Wiesener

Hypoxia and renal injury

 

 

 

Dr. Michael S. Wiesener
Department of Nephrology and Hypertension
University of Erlangen-Nuremberg
Erlangen, Germany
 

 

hallan

Intrauterine growth and the risk of CKD in adulthood

 

 

johnson

Fructose, the metabolic syndrome and renal disease

 

 

Prof Stein Hallan
Department of Medicine
Division of Nephrology
St. Olav University Hospital
Trondheim, Norway

Prof Richard J. Johnson
Temple Hoyne Buell and NKF of Colorado Endowed
Division of Renal Diseases and Hypertension
University of Colorado
Denver, CO, USA

       

ritz

Obesity and metabolic syndrome: an emerging threat to renal function

 

 

 

Prof Eberhard Ritz
Dept. Internal Medicine
Division Nephrology
Heidelberg, Germany
 

 

stel

Recent trends in the epidemiology of renal replacement therapy: good news for the nephrologist?

 

caskey

The EVEREST study: exploring the worldwide variation in RRT incidence

 

Dr Vianda Stel
ERA-EDTA Registry - Dept. of Medical Informatics
Academic Medical Center
Amsterdam, The Netherlands

Dr Fergus Caskey
UK Renal Registry
Southmead Hospital
Bristol, United Kingdom

       

tomson

The launch of new ERA-EDTA codes for primary renal diagnosis

 

 

 

Dr Charles Tomson
Department of Nephrology
Southmead Hospital
Bristol, United Kingdom
 

 

soler romeo

ACE2 and chronic kidney disease

 

 

 

fujita

Modification of mineralocorticoid receptor function in proteinuric kidney disease

 

 

Dr. Maria Josè Soler Romeo
Nephrology Department
Hospital del Mar Barcelona
Barcelona, Spain

Dr. Toshiro Fujita
Department of Nephrology and Endocrinology
University of Tokyo Graduate School of Medicine
Tokyo, Japan

       

raizada

ACE2: a new target for cardiovascular disease therapeutics

 

burnier

Clinical value of aldosterone antagonism

Prof. Mohan Raizada
Department of Physiology and Functional Genomics
University of Florida, College of Medicine
Gainesville, FL, USA
Prof. Michel Burnier
Division of Nephrology and Hypertension Consultation
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
   
nishiyama

Role of aldosterone in oxidative stress and renal injury

 
Prof. Akira Nishiyama
Department of Pharmacology
Kagawa University Medical School
Kagawa, Japan
 

 

blake

Peritoneal dialysis and hemodialyis therapy in elderly patients

 

 

krediet

Peritoneal membrane evaluation in clinical practice

 

 

 

Dr. Peter Blake
London Health Sciences Centre
Victoria Hospital
London, Ontario, Canada

Prof. R. Krediet
Chief Division of Nephrology
Academic Medical Centre
Amsterdam, The Netherlands

       

topley

Maintaining the peritoneal membrane - from pathophysiology to clinic

 

witowski

Mesothelial cell biology and its alterations in PD

Prof Nicholas Topley
Institute of Nephrology
School of Medicine, Cardiff University
Cardiff, United Kingdom
Prof Janusz Witowski
Department of Pathophysiology
Poznań University of Medical Sciences
Poznań, Poland

 

aachen university

Relative roles of promoters and inhibitors of vascular calcification in CRF

 

raggi

Imaging vascular calcifications: precision, x-ray exposure, cost and predictive value

 

 

Prof Ralf Westenfeld
Department of Nephrology
Rheinisch-Westfälische Technische Hochschule (RWTH)
Aachen University Hospital
Aachen, Germany

Prof Paolo Raggi
Division of Cardiology and Department of Medicine
Emory University
Atlanta, GA, USA

       

Université Paris Decartes

Ionized, corrected, or total serum calcium in CKD? An unresolved clinical issue

 

lafage-proust

ROD: definition, classification, diagnosis, indications of bone biopsy

Prof Pascal Houillier
Département de Physiologie et radio-isotopes
AP-HP, Hôpital Européen Georges Pompidou
Paris, France
Prof Marie-Helene Lafage-Proust
Université de Lyon
Institut National de la Santé et de la Recherche Medical
(INSERM) 890, CHU
Saint-Etienne, France
   
universidade nova de lisboa

Diagnosis of ROD by circulating surrogate markers compared with bone histology

 

 
Prof Anibal Ferreira
Department of Nephrology
Hospital Curry Cabral and Faculdade de Ciências Médicas
Universidade Nova de Lisboa
Lisbon, Portugal
 

 

kronenberg

Determinants of long term progression - results from the MMKD study

 

 

remuzzi

Magic bullet or multiple interventions to reverse kidney disease progression?

 

 

Prof F. Kronenberg
Division of Genetic Epidemiology
Department of Medical Genetics
Molecular and Clinical Pharmacology
Innsbruck Medical University
Innsbruck, Austria

Prof G. Remuzzi
Mario Negri Institute for Pharmacological Researches
Negri Bergamo Laboratories
Bergamo, Italy

       

brunskill

Tubular toxicity of proteinuria

 

Hou

Anti-proteinuric doses of RAS inhibitors: efficacy for renoprotection

Prof N.J. Brunskill
Department of Infection, Immunity and Inflammation
University of Leicester
Leicester, United Kingdom
Prof F.F. Hou
Division of Nephrology
Nanfang Hospital
Southern Medical University
Guangzhou, P.R.China
   
kerjaschki

The complexity of the filtration barrier

 
Prof D. Kerjaschki
Department of Pathology
Medical University of Vienna
Allgemeines Krankenhaus
Vienna, Austria
 

 

umc

Hepcidin - bringing new knowledge of molecular mechanisms into the clinic

 

 

cannata

How well controlled is hyperparathyroidism in today's practice? The magnitude of the problem

 

Dr Dorine W. Swinkels
Department of Clinical Chemistry
Radboud University Nijmegen Medical Centre
Nijmegen, The Netherlands

Prof J. Cannata-Andia
Servicio de Metabolismo Oseo y Mineral
Instituto “Reina Sofía” de Investigación.
REDinREN – ISCIII.
Hospital Universitario Central de Asturias.
Universidad de Oviedo
Oviedo, Spain

       

dusso

Mechanisms underlying parathyroid hyperplasia

 

silver

Bone as an endocrine organ: FGF 23 and the parathyroid

Dr. Adriana S. Dusso
Renal Division
Washington University School of Medicine
St. Louis, MO, USA
Prof Justin Silver
Department of Nephrology and Hypertension
Hadassah University Hospital
Ein-Karem, Jerusalem

 

kumar

Intestinal signals regulate renal solute excretion

 

 

 

bagrov

Cardiotonic steroids (endogenous digitalis)

 

 

 

Dr R. Kumar
Division of Nephrology and Hypertension
Department of Medicine, Mayo Clinic
Rochester, MN, USA

Dr Alexei Y. Bagrov
Laboratory of Cardiovascular Science
National Institute on Aging, NIH
Baltimore, MD, USA

       

logotitze

Non-osmotic sodium storage

 

rodrigueziturbe

Management of the ckd patient: salt restriction, diuretics or both?

Dr Jens Titze
Medizinische Klinik 4
Nikolaus-Fiebiger Center for Molecular Medicine
Erlangen, Germany
Prof B. Rodriguez-Iturbe
Hospital Universitario de Maracaibo
Centro de Investigaciones Biomedicas
Maracaibo, Venezuela

 

jayne

The role of rituximab in vasculitis therapy

 

 

kain

New experimental data on the pathogenesis of ANCA associated vasculitis

 

 

Dr David Jayne
University of Cambridge
School of Clinical Medicine
Addenbrooke's Hospital
Cambridge, United Kingdom

Dr Renate Kain
Institute of Clinical Pathology
Medical University of Vienna
Vienna, Austria

       

diamond

B cells and the kidney

 

pusey

Lupus nephritis: clinical trials and novel therapies

Dr Betty Diamond
The Feinstein Institute for Medical Research
Center of Autoimmune and Musculoskeletal Diseases
Manhasset, NY, USA
Dr Charles Pusey
Faculty of Medicine
Imperial College
London, United Kingdom
   

 

fouque

Diagnostic criteria for protein-energy wasting

 

 

 

mitch

Therapeutic interventions for protein-energy wasting in chronic kidney diseases

 

 

 

Dr Denis Fouque
Department of Nephrology
Hospital Edouard Herriot
University Lyon 1
Lyon, France

Prof. William E. Mitch
Department of Nephrology
Hospital Edouard Herriot
University Lyon 1
Lyon, France

       

davenport

Achieving blood pressure control and the risk of intradialytic hypotension

 

 

Dr Andrew Davenport
University College London
Center for Nephrology
Royal Free Hospital
London, United Kingdom
 

 

glassock

Evidence-based therapy for idiopathic membranous nephropathy-2009

 

 

harris

Immune mechanisms of interstitial inflammation in membranous nephropathy

 

 

Prof. Richard Glassock
The David Geffen School of Medicine
at UCLA
Los Angeles, CA, USA

Prof. David Harris
Department of Renal Medicine and Transplantation
The University of Sydney at Westmead Hospital
Westmead, Australia

       

ponticelli

Natural history and prognostic factors

quigg

Complement components in membranous nephropathy

Prof C. Ponticelli
IRCCS Istituto Auxologico Italiano
Milan, Italy
Prof. Richard J. Quigg
Section of Nephrology
University of Chicago
Chicago, IL, USA
   
bruijn

Interstitial and infection related nephritis

 

 

 

   
Prof. Jan A. Bruijn
Department of Pathology
Leiden University Hospital
Leiden, The Netherlands
 

 

azizi

Blood pressure effects of VEGF antagonism

 

 

 

Maynard

VEGF antagonism as a cause of preeclampsia

 

 

 

 

 

Dr Michel Azizi
Clinical Investigation Center, Inserm
George Pompidou European Hospita, APHP
Paris, France

Dr Sharon E. Maynard
School of Medicine
George Washington University
Washington, D.C., USA

       

fliser

ADMA, blood pressure and renal function: from saltsensitivity to heart failure

zoccali

ADMA, endothelial dysfunction and the risk of cardiovascular and renal diseases

Prof D. Fliser
Renal and Hypertensive Disease
University Medical Centre
Homburg/Saar, Germany
Prof C. Zoccali
Unità di Nefrologia, Dialisi, Trapianto e Ipertensione
OO.RR and CNR Istituto di Biomedicina
Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione
Reggio Calabria, Italy
   
lamas

Classical and non classical nitric oxide signaling in vascular disease

 

 

   
Dr S. Lamas
Centro Nacional de Investigaciones Cardiovasculares
Consejo Superior de Investigaciones Científicas
Madrid, Spain
 

 

UB

New membranes

 

 

lachmann

Use of the serum free light chain assay

 

 

 

 

Dr Colin A. Hutchison
Department of Nephrology
University Hospital Birmingham
Birmingham, United Kingdom

Dr Helen J. Lachmann
UK National Amyloidosis Centre
University College London Medical School
London, United Kingdom

       

madore

The use of plasmapheresis

loirat

Indications to plasma infusion and plasma exchange

Dr François Madore
University of Montréal
Hôpital du Sacré-Coeur de Montréal
Montréal, Quebec, Canada
Prof. C. Loirat
Service de Nephrologie Pediatrique
Hopital Robert Debre
Paris, France
   
BU

Natural course and perspectives for medical therapy in AA amyloidosi

 

   
Dr. Martha Skinner
Amyloid Treatment and Research Program
Boston University School of Medicine
Boston, USA
 

 

warnock

The renal epithelial sodium channel and hypertension

 

jeunemaitre

WNK kinases and hypertension

 

 

 

Prof David G. Warnock
Department of Nephrology
University of Alabama at Birmingham
Birmingham, AL, USA

Prof Xavier Jeunemaitre
INSERM U772
Collège de France
Paris, France

       

cusi

Finding the genes of hypertension: lessons from the hypergenes project

luft

Lessons from autosomal dominant hypertension and brachydactylie

Prof Daniele Cusi
Division of Nephrology and Dialysis
San Carlo Borromeo Hospital
Milano, Italy
Prof Friedrich C. Luft
Charité Campus Buch
Experimental and Clinical Research Center (ECRC)
Berlin, Germany
   
kalra

ASTRAL study: results and implications

beutler

Results of the STAR study

Dr Philip A. Kalra
Department of Renal Medicine
Salford Royal Hospital
Salford, United Kingdom
Dr. Jaap J. Beutler
Jeroen Bosch Hospital, Den Bosch
University Medical Center
Utrecht, The Netherlands

 

opelz

Long-term kidney graft survival - are we doing any better?

 

 

 

rondeau

Early EMT in renal grafts is correlated with outcome

 

 

 

Prof Gerhard Opelz
Department of Transplantation Immunology
University of Heidelber
Heidelberg, Germany

Prof Eric Rondeau
Service de Nephrologie A
Hopital Tenon
Paris, France

       

haller

The pro and con of protocol biopsies

wetzels

Renin-angiotensin system blockade in kidney transplantation

Prof Hermann Haller
Division of Nephrology
Department of Medicine, School of Medicine
University of Hannover
Hannover, Germany
Prof Jack F.M. Wetzels
Department of Nephrology
Radboud University Nijmegen
Nijmegen, The Netherlands

 

baylor

Progression of FABRY nephropathy

 

 

 

wanner

Treatment choices for FABRY nephropathy

 

 

 

Dr R. Schiffmann
Institute of Metabolic Disease
Baylor Research Institute
Dallas, TX, USA

Prof C.Wanner
Bayerische-Julius-Maximilans University
Department of Medicine, Division of Nephrology
Würzburg, Germany

       
mignani

Transplant, dialysis and CVD in FABRY disease

   
Dr R. Mignani
Renal Unit
Infermi Hospital
Rimini, Italy
 

 

cuppari

Evaluation of physical activity in CKD: applicability of simple too

 

 

koufaki

Asessment of functional capacity in CKD patients

 

 

 

 

Dr L. Cuppari
Division of Nephrology
Federal University of Sao Paulo
Sao Paulo, Brazil

Dr P. Koufaki
Department of Sports and Exercise Science
Stirling University
Stirling, United Kingdom

       
feldt-rasmussen

Growth hormone improves nutrition, quality of life and cardiovascular risk factors in ESRD

   
Dr B. Feldt-Rasmussen
Department of Nerphrology
Rigshospitalet
Copenhagen, Denmark
 

 

kumar

Intestinal phosphate absorption: cross-talk with the kidney

 

 

 

murer

Molecular control of renal phosphate reabsorption

 

 

 

Dr R. Kumar
Division of Nephrology and Hypertension
Department of Medicine, Mayo Clinic
Rochester, MN, USA

Prof. Heini Murer
Center for Integrative Human Physiology
University of Zurich
Zurich, Switzerland

       
O'Neill Phosphate, pyrophosphate and bisphosphonates in uremic vascular calcification fukagawa FGF23 and klotho in patients with CKD
Prof. W. Charles O'Neill
Renal Division
Emory University
Atlanta, GA, USA
Dr. M. Fukagawa
Division Nephrology and Kidney Center
Kobe University School of Medicine
Kobe, Japan

 

gnudi

The interplay between hyperglycemia and vascular hemodynamics

 

 

 

 

miyata

Advanced glycation, hypoxia and oxidative stress

 

 

 

 

Dr. Luigi Gnudi
Unit for Metabolic Medicine, Cardiovascular Division
King's College London
London, United Kingdom

Prof. T. Miyata
Center for Translational and Advanced Research
Tohoku University Graduate School of Medicine
Sendai, Japan

 

gaslini

An integrated proteomic approach to plasma and urinary proteins in nephrotic syndrome

 

 

 

gubler

FSGS - primary vs. Secondary forms, congenital mutations vs non-genetic types

 

 

 

Dr. G.M. Ghiggeri
Department of Nephrology
Dialysis and Transplantation
Giannina Gaslini Children Hospital
Genova, Italy

Dr. M.C. Gubler
Inserm U574, Ventre de reference MARHEA
Hopital Necker - Enfant Malades
Université Paris Descartes
Paris, France

       
kasr el aini Tropical infections and glomerulonephritis
   
Dr. M.R. Francis
Pathology Department
Kasr El Aini Faculty of Medicine
Cairo, Egypt
 

 

fehr

Fairness (and its limits) in humans

 

 

alitalo

Lymphangiogenesis in development and disease

 

 

Prof. E. Fehr
Institute for Empirical Research in Economics
University of Zurich
Zurich, Switzerland

Prof. K. Alitalo
Molecular/Cancer Biology Laboratory
Biomedicum Helsinki and Department of Pathology
Haartman Institute, University of Helsinki
Helsinki, Finland

       
hausenloy

Remote ischemic preconditioning

 

 

 

 

 

 

Dr. D.M. Hausenloy
The Hatter Cardiovascular Institute
University College London
London, United Kingdom